Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 3, 1996, Pages 919-925

  Chung, Joyce ^b   Henry, Robert R ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; SOMATOMEDIN B; SOMATOSTATIN;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HEMANGIOPERICYTOMA; HORMONAL THERAPY; HUMAN; HYPOGLYCEMIA; LIPID METABOLISM; MALE; PRIORITY JOURNAL;

ABDOMINAL NEOPLASMS; BLOOD GLUCOSE; GLUCOSE; GROWTH SUBSTANCES; HEMANGIOPERICYTOMA; HORMONES; HUMANS; HYPOGLYCEMIA; LEG; LIPID METABOLISM; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBESITY; OXIDATION-REDUCTION; SKIN DISEASES; SOMATOSTATIN;

EID: 0029958912     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.3.919     Document Type: Article

References (40)

1. Doege KW. 1930 Fibrosarcoma of the mediastinum. Ann Surg. 92:455-460.
2. Daughaday WH. 1989 Hypoglycemia in patients with non-islet cell tumors. Endocrinol Metab Clin North Am. 18:91-101.
3. Kahn CR. 1980 The riddle of tumor hypoglycemia revisited. Clin Endocrinol Metab. 9:335-360.
4. Megyesi K, Kahn CR, Roth J, Gorden P. 1974 Hypoglycemia in association with extrapancreatic tumors: demonstration of elevated plasma NSILA-s by a new radioreceptor assay. J Clin Endocrinol Metab. 38:931-934.
5. Unger RH. 1966 The riddle of tumor induced hypoglycemia. Am J Med. 40:325-330.
6. Zapf J, Walter H, Froesch ER. 1981 Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest. 68:1321-1330.
7. Daughaday WH, Trivedi B, Kapadia M. 1981 Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia. J Clin Endocrinol Metab. 53:289-294.
8. Widmer U, Zapf J, Froesch ER. 1482 Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II? J Clin Endocrinol Metab. 55:883-889.
9. Daughaday WH, Emanuelle MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P. 1988 Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med. 319:1434-1440.
10. Lowe WL, Roberts CT, LeRoith D, et al. 1989 Insulin-like growth factor-II in non-islet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acid. J Clin Endocrinol Metab. 69:1153-1159.
11. Shapiro ET, Bell GI, Polonsky KS, et al. 1990 Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II. J Clin Invest. 85:1672-1679.
12. National Diabetes Data Group. 1979 Classification and diagnosis of diabetes mellitus and other categories of glucose tolerance. Diabetes. 28:1039-1057.
13. Steele R. 1959 Influence of glucose loading and injected insulin on hepatic glucose output. Ann NY Acad Sci. 82:420-430.
14. Thorburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR. 1990 Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest. 85:522-529.
15. Baron AD, Brechtel G, Wallace P, Edelman SV. 1988 Rates and tissue sites of non-insulin and insulin-mediated glucose uptake in humans. Am J Physiol. 255:E769-E74.
16. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. 1981 The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 30: 1000-1007.
17. Faloona GR, Unger RH. 1975 Methods of hormone radioimmunoassay. In: Jaffe BM, Berman HR, eds. Glucagon. New York: Academic Press; 317-330.
18. Itaya K, Vi M. 1965 Calorimetric determination of free fatty acids in biological fluids. J Lipid Res. 6:16-20.
19. Morgan CR, Lazarow A. 1963 Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes. 12: 115-126.
20. Faber OK, Binder C, Markussen J, et al. 1978 Characterization of seven C-peptide antisera. Diabetes. 27(Suppl 1):170-177.
21. Giegel JL, Brotherton MM, Cronin P, et al. 1982 Radial partition immunoassay. Clin Chem. 28:1894-1898.
22. Daughaday WH, Parker KA, Borowsky S, Trivedi B, Kapadia M. 1982 Measurement of somatostatin-related peptides in fetal neonatal and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA) and multiplication stimulating activity RRA after acid ethanol extraction. Endocrinology. 110:575-581.
23. Perdue JF, Chan JK, Thibault C, Radaj P, Bills B, Daughaday WH. 1983 The biochemical characterization of detergent-solubilized insulin-like growth factor II receptors from rat placenta. J Biol Chem. 285:7800-7811.
24. Daughaday WH, Trivedi B, Baxter RC. 1995 Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of serum free IGF-II. Endocr J. 3:425-428.
25. Perdue JF, Gowan LK, Hudgins RW, Schevermann J, Foster B, Northcutt-Brown S. 1991 Development of a specific radioimmunoassay for E-domain containing forms of insulin-like growth factor II In: Raizada MK, LeRoith D, eds. Molecular biology and physiology of insulin-like growth factors. New York: Plenum Press; 45-56.
26. Eastman RC, Carson RE, Orloff DG, et al. 1992 Glucose utilization in a patient with hepatoma and hypoglycemia: assessment by a positron emission tomography. J Clin Invest. 89:1958-1963.
27. Moller N, Blum WF, Mengel A, Hansen LB, Alberti KGMM, Schmitz O. 1991 Basal and insulin stimulated metabolism in tumor induced hypoglycaemia; evidence for increased muscle glucose uptake. Diabetologia. 34:17-20.
28. LeRoith D, Clemmons D, Nissley P, Rechler MM. 1992 Insulin-like growth factors in health and disease. Ann Intern Med. 116:854-862.
29. Phillips LS, Robertson DG. 1993 Insulin-like growth factors and non-islet cell tumor hypoglycemia. Metabolism. 42:1093-1101.
30. Enjoh T, Hizuka N, Fukuda I, et al. Characterization of new monoclonal antibodies to human insulin-like growth factor II and their application in Western immunoblot analysis [Abstract]. Proc of the 74th Annual Meet of The Endocrine Soc. 1992; 80.
31. Daughaday WH, Trivedi B. 1992 Measurement of derivatives of proinsulin-like growth factor II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab. 75:110-115.
32. Guler HP, Zapf J, Schmid C, et al. 1989 Insulin-like growth factors 1 and 2 in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh). 121:753-758.
33. Baxter RC, Daughaday WH. 1991 Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors. J Clin Endocrinol Metab. 73:696-702.
34. Zapf J, Schmid Ch, Guler HP, et al. 1990 Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein II during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest. 86:952-961.
35. Zapf J. 1993 IGFs: function and clinical importance. III. Role of insulin-like growth factor (IGF) II and IGF binding proteins in extrapancreatic tumor hypoglycemia. J Intern Med. 234:543-552.
36. Wing JR, Panz VR, Joffe BI, et al. 1991 Hypoglycemia in hepatocellular carcinoma: failure of short-term growth hormone administration to reduce enhanced glucose requirements. Metabolism. 40:508-515.
37. Daughaday WH, Kapadia M. 1989 Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci USA. 86:6778-6782.
38. Rizza RA, Cryer PE, Gerich JE. 1979 Role of glucagon, epinephrine and growth hormone in human glucose counterregulation: effects of somatostatin and adrenergic blockade on plasma glucose recovery and glucose flux rates following insulin induced hypoglycemia. J Clin Invest. 64:62-71.
39. Teale JD, Blum WF, Marks V. 1992 Alleviation of non-islet cell tumor hypoglycemia by growth hormone therapy is associated with changes in IGF binding protein-3. Ann Clin Biochem. 29:314-323.
40. DeFeo P, Periello G, Torlone E, et al. 1989 Demonstration of a role for growth hormone in glucose counterregulation. Am J Physiol. 256:E835-E843.